Casein Kinase 2 dependent phosphorylation of neprilysin regulates receptor tyrosine kinase signaling to Akt

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Siepmann, Martin ^a   Kumar, Sathish ^a   Mayer, Günter ^a   Walter, Jochen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; INSULIN; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SOMATOMEDIN C;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CASEIN KINASE II; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NEPRILYSIN; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; SURFACE PLASMON RESONANCE;

EID: 78049276342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013134     Document Type: Article

References (56)

1. Kenny J (1993) Endopeptidase-24.11: putative substrates and possible roles. Biochem Soc Trans 21(Pt 3): 663-668.
2. Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, et al. (1991) CD10/ neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci U S A 88: 10662-10666.
3. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, et al. (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292: 1550-1552.
4. Hemming ML, Patterson M, Reske-Nielsen C, Lin L, Isacson O, et al. (2007) Reducing amyloid plaque burden via ex vivo gene delivery of an Abetadegrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med 4: e262.
5. Stewart JR, Kenny AJ (1984) Proteins of the kidney microvillar membrane. Biosynthesis of endopeptidase-24.11, dipeptidylpeptidase IV and aminopeptidases N and A in pig kidney slices. Biochem J 224: 549-558.
6. Lafrance MH, Vezina C, Wang Q, Boileau G, Crine P, et al. (1994) Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11. Biochem J 302(Pt 2): 451-454.
7. Iwase A, Shen R, Navarro D, Nanus DM (2004) Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins. J Biol Chem 279: 11898-11905.
8. Nelson JB, Carducci MA (2000) Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer. Cancer Invest 18: 87-96.
9. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, et al. (1998) Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 4: 50-57.
10. Sumitomo M, Iwase A, Zheng R, Navarro D, Kaminetzky D, et al. (2004) Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell 5: 67-78.
11. Terawaki S, Kitano K, Hakoshima T (2007) Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complex. J Biol Chem 282: 19854-19862.
12. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, et al. (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140: 647-657.
13. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, et al. (1998) Ezrin/ radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 140: 885-895.
14. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, et al. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362.
15. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
16. Weng LP, Smith WM, Brown JL, Eng C (2001) PTEN inhibits insulinstimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum Mol Genet 10: 605-616.
17. Koul D (2008) PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7: 1321-1325.
18. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378.
19. Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3- kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
20. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
21. Arimura Y, Shiroki F, Kuwahara S, Kato H, Dianzani U, et al. (2004) Akt is a neutral amplifier for Th cell differentiation. J Biol Chem 279: 11408-11416.
22. Carracedo A, Pandolfi PP (2008) The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27: 5527-5541.
23. Plas DR, Thompson CB (2005) Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24: 7435-7442.
24. Xu Z, Stokoe D, Kane LP, Weiss A (2002) The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth Differ 13: 285-296.
25. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, et al. (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8: 1195-1198.
26. Blanco-Aparicio C, Renner O, Leal JF, Carnero A (2007) PTEN, more than the AKT pathway. Carcinogenesis 28: 1379-1386.
27. Vazquez F, Devreotes P (2006) Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 5: 1523-1527.
28. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, et al. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323-334.
29. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20: 5010-5018.
30. Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, et al. (2001) Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276: 48627-48630.
31. Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, et al. (2006) A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126: 269-283.
32. Piazza FA, Ruzzene M, Gurrieri C, Montini B, Bonanni L, et al. (2006) Multiple myeloma cell survival relies on high activity of protein kinase CK2. Blood 108: 1698-1707.
33. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, et al. (2001) Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20: 3247-3257.
34. Daya-Makin M, Sanghera JS, Mogentale TL, Lipp M, Parchomchuk J, et al. (1994) Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res 54: 2262-2268.
35. Seldin DC, Leder P (1995) Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science 267: 894-897.
36. Ganju RK, Shpektor RG, Brenner DG, Shipp MA (1996) CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase. Blood 88: 4159-4165.
37. Walter J, Grunberg J, Schindzielorz A, Haass C (1998) Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms. Biochemistry 37: 5961-5967.
38. Tamboli IY, Prager K, Thal DR, Thelen KM, Dewachter I, et al. (2008) Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis. J Neurosci 28: 12097-12106.
39. Rentmeister A, Bill A, Wahle T, Walter J, Famulok M (2006) RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of betasecretase BACE1 in vitro. Rna 12: 1650-1660.
40. Wahle T, Thal DR, Sastre M, Rentmeister A, Bogdanovic N, et al. (2006) GGA1 is expressed in the human brain and affects the generation of amyloid beta-peptide. J Neurosci 26: 12838-12846.
41. Jonsson U, Fagerstam L, Ivarsson B, Johnsson B, Karlsson R, et al. (1991) Realtime biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11: 620-627.
42. O'Shannessy DJ, Brigham-Burke M, Soneson KK, Hensley P, Brooks I (1993) Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem 212: 457-468.
43. Marin O, Meggio F, Pinna LA (1994) Design and synthesis of two new peptide substrates for the specific and sensitive monitoring of casein kinases-1 and -2. Biochem Biophys Res Commun 198: 898-905.
44. Faust M, Montenarh M (2000) Subcellular localization of protein kinase CK2. A key to its function? Cell Tissue Res 301: 329-340.
45. Guerra B, Boldyreff B, Sarno S, Cesaro L, Issinger OG, et al. (1999) CK2: a protein kinase in need of control. Pharmacol Ther 82: 303-313.
46. Sarno S, Pinna LA (2008) Protein kinase CK2 as a druggable target. Mol Biosyst 4: 889-894.
47. Pinna LA (2002) Protein kinase CK2: a challenge to canons. J Cell Sci 115: 3873-3878.
48. Guerra B, Issinger OG (1999) Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20: 391-408.
49. McKendrick L, Milne D, Meek D (1999) Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable. Mol Cell Biochem 191: 187-199.
50. Lin R, Beauparlant P, Makris C, Meloche S, Hiscott J (1996) Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affectsintrinsic protein stability. Mol Cell Biol 16: 1401-1409.
51. Meggio F, Pinna LA (2003) One-thousand-and-one substrates of protein kinase CK2? Faseb J 17: 349-368.
52. Fleming Y, Armstrong CG, Morrice N, Paterson A, Goedert M, et al. (2000) Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J 352(Pt 1): 145-154.
53. Kim SO, Hasham MI, Katz S, Pelech SL (1998) Insulin-regulated protein kinases during postnatal development of rat heart. J Cell Biochem 71: 328-339.
54. Roher N, Miro F, Jose M, Trujillo R, Plana M, et al. (1998) Protein kinase CK2 is altered in insulin-resistant genetically obese (fa/fa) rats. FEBS Lett 437: 211-215.
55. Torres J, Pulido R (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276: 993-998.
56. Rahdar M, Inoue T, Meyer T, Zhang J, Vazquez F, et al. (2009) A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A 106: 480-485.